Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
De La Mora L, Ugarte A, Martínez-Rebollar M, De Lazzari E, García-Hernández D, Font G, De Loredo N, Solbes E, Miquel L, Blanch J, Torres B, Riera J, Chivite I, Ambrosioni J, Inciarte A, González-Cordón A, Martínez E, Blanco JL, Mallolas J, Laguno M. De La Mora L, et al. Among authors: chivite i. AIDS Behav. 2022 Dec;26(12):4055-4062. doi: 10.1007/s10461-022-03730-5. Epub 2022 Jun 22. AIDS Behav. 2022. PMID: 35732910 Free PMC article.
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
Palacio-Vieira J, Moreno-Fornés S, Díaz Y, Aceitón J, Bruguera A, Nomah DK, Llibre JM, Knobel H, Chivite I, Miro JM, Domingo P, Suanzes P, Fanjul F, Navarro G, Macorigh L, Mera A, Casabona J, Imaz A, Reyes-Urueña J; PISCIS study group. Palacio-Vieira J, et al. Among authors: chivite i. HIV Med. 2023 Sep;24(9):965-978. doi: 10.1111/hiv.13486. Epub 2023 Mar 29. HIV Med. 2023. PMID: 36990962
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
Laguno M, Ugarte A, Martinez-Rebollar M, Sobrino Y, Font G, de Lazzari E, de la Mora L, Torres B, Chivite I, Riera J, Ambrosioni J, Inciarte A, González-Cordón A, Rojas J, Cordón E, Blanco JL, Martínez E, Mallolas J. Laguno M, et al. Among authors: chivite i. Enferm Infecc Microbiol Clin (Engl Ed). 2021 May 24:S0213-005X(21)00178-6. doi: 10.1016/j.eimc.2021.04.005. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34045097 Free article. English, Spanish.
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review.
Palacio-Vieira J, Reyes-Urueña JM, Imaz A, Bruguera A, Force L, Llaveria AO, Llibre JM, Vilaró I, Borràs FH, Falcó V, Riera M, Domingo P, de Lazzari E, Miró JM, Casabona J; PICIS study group. Palacio-Vieira J, et al. BMC Public Health. 2021 Aug 28;21(1):1596. doi: 10.1186/s12889-021-11613-y. BMC Public Health. 2021. PMID: 34454444 Free PMC article. Review.
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falcó V, Imaz A, Cortés C, Force L, Letang E, Vilaró I, Casabona J, Miro JM; PISCIS study group. Nomah DK, et al. Lancet HIV. 2021 Nov;8(11):e701-e710. doi: 10.1016/S2352-3018(21)00240-X. Epub 2021 Oct 13. Lancet HIV. 2021. PMID: 34655549 Free PMC article.
Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections.
de Lazzari E, Martínez-Mimbrero A, Chivite I, González-Cordón A, Mosquera MM, Laguno M, Costa J, Bosch J, Blanco JL, Álvarez-Martinez M, Ugarte A, Inciarte A, de la Mora L, Torres B, Martínez-Rebollar M, Ambrosioni J, Fernaández E, Hurtado JC, Mallolas J, Miró JM, Marcos MA, Martínez E. de Lazzari E, et al. Among authors: chivite i. AIDS. 2022 May 1;36(6):829-838. doi: 10.1097/QAD.0000000000003164. Epub 2022 Feb 16. AIDS. 2022. PMID: 35013084
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre.
Ambrosioni J, Rojas Liévano J, Berrocal L, Inciarte A, de la Mora L, González-Cordón A, Martínez-Rebollar M, Laguno M, Torres B, Ugarte A, Chivite I, Leal L, de Lazzari E, Miró JM, Blanco JL, Martinez E, Mallolas J. Ambrosioni J, et al. Among authors: chivite i. J Antimicrob Chemother. 2022 Mar 31;77(4):1133-1139. doi: 10.1093/jac/dkab481. J Antimicrob Chemother. 2022. PMID: 35040990
41 results